Treatment of high risk symptomatic intracranial atherosclerosis with balloon mounted coronary stents and Wingspan stents: single center experience over a 10 year period.

@article{Tarlov2012TreatmentOH,
  title={Treatment of high risk symptomatic intracranial atherosclerosis with balloon mounted coronary stents and Wingspan stents: single center experience over a 10 year period.},
  author={Nicholas E Tarlov and R Jahan and Jeffrey L. Saver and James W. Sayre and Latisha K. Ali and Doojin Kim and Gary R. Duckwiler and Satoshi Tateshima and Fernando Vi{\~n}uela and David S. Liebeskind},
  journal={Journal of neurointerventional surgery},
  year={2012},
  volume={4 1},
  pages={34-9}
}
BACKGROUND Stenting of symptomatic intracranial atherosclerosis remains under investigation, yet this option to potentially avert subsequent stroke has been offered at select centers under humanitarian device exemption and off-label use for several years. METHODS Retrospective case series of consecutive patients undergoing stenting with Wingspan and balloon mounted coronary stents for symptomatic intracranial atherosclerosis at a single institution. Recurrent symptomatic ischemia in the… CONTINUE READING